BUDGET IMPACT OF ALBUMIN-BOUND PACLITAXEL plus GEMCITABINE IN THE TREATMENT OF METASTATIC PANCREATIC CANCER

被引：1
|
作者：
Binder, G. [1 ]
Whiting, S. [1 ]
Milentijevic, D. [2 ]
Penenberg, D. [3 ]
Wei, X. [3 ]
Kayitalire, L. [1 ]
Renschler, M. F. [1 ]
机构：
[1] Celgene Corp, Summit, NJ USA
[2] Market Access Solut, Raritan, NJ USA
[3] Celgene Corp, Berkeley Hts, NJ USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.435
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN40
引用
收藏
页码：A74 / A74
页数：1
相关论文
共 50 条
  • [31] Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer
    Roviello, G.
    Conter, F. U.
    Mini, E.
    Generali, D.
    Traversini, M.
    Lavacchi, D.
    Nobili, S.
    Sobhani, N.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (04) : 669 - 677
  • [32] Cystoid Macular Edema following Treatment with Nanoparticle Albumin-Bound Paclitaxel and Atezolizumab for Metastatic Breast Cancer
    Yamane, Hiroaki
    Itagaki, Tomoko
    Kajitani, Keiko
    Koura, Yuji
    Kawabuchi, Yoshiharu
    Ohara, Masahiro
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 1121 - 1128
  • [33] Nanoparticle albumin-bound paclitaxel is superior to liposomal paclitaxel in the neoadjuvant treatment of breast cancer
    Zhang, Weiwei
    Xu, Yinggang
    Shi, Xiaoqing
    Huang, Xiaofeng
    Chen, Rui
    Xu, Haiping
    Shi, Wenjie
    Wan, Xinyu
    Wang, Ye
    He, Jinzhi
    Li, Cuiying
    Wang, Jue
    Zha, Xiaoming
    NANOMEDICINE, 2022, 17 (10) : 683 - 694
  • [34] Combined Therapy With Gemcitabine Hydrochloride and Nanoparticle Albumin-bound Paclitaxel Enabled Resection in a Patient With Unresectable Locally Advanced Pancreatic Cancer
    Sakaue, Takahiko
    Fukahori, Masaru
    Miwa, Keisuke
    Ushijima, Tomoyuki
    Yasumoto, Makiko
    Kuraoka, Kei
    Ishida, Yuusuke
    Nagasu, Sachiko
    Ishikawa, Hiroto
    Mihara, Yuutarou
    Nakayama, Masamichi
    Naitou, Yoshiki
    Okabe, Yoshinobu
    Torimura, Takuji
    PANCREAS, 2019, 48 (06) : 859 - 859
  • [35] Albumin-bound paclitaxel (Abraxane) for advanced breast cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2005, 47 (1208): : 39 - 40
  • [36] Camrelizumab combined with apatinib and albumin-bound paclitaxel followed by camrelizumab plus apatinib as first-line therapy for unresectable or metastatic pancreatic cancer.
    Shen, Bo
    Wu, Yuan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 703 - 703
  • [37] Efficacy of gemcitabine in combination with nanoparticle albumin-bound paclitaxel in the treatment of recurrent ovarian cancer: A retrospective single institution review
    Kase, Adam M.
    Azzouqa, Abdel-Ghani
    Kochuveettil, Swapna
    Colon-Otero, Gerardo
    CANCER MEDICINE, 2023, 12 (08): : 9434 - 9438
  • [38] Cost-effectiveness of nanoparticle albumin-bound paclitaxel versus docetaxel in the treatment of metastatic breast cancer.
    Gradishar, W
    Vishalpura, T
    Franklin, M
    Bramley, T
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S220 - S221
  • [39] Impact of gemcitabine on the treatment of metastatic pancreatic cancer
    Ishii, H
    Furuse, J
    Nagase, M
    Yoshino, M
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (01) : 62 - 66
  • [40] Preclinical Investigation of Nanoparticle Albumin-Bound Paclitaxel as a Potential Treatment for Adrenocortical Cancer
    Demeure, Michael J.
    Stephan, Elizabeth
    Sinari, Shripad
    Mount, David
    Gately, Steven
    Gonzales, Paul
    Hostetter, Galen
    Komorowski, Richard
    Kiefer, Jeff
    Grant, Clive S.
    Han, Haiyong
    von Hoff, Daniel D.
    Bussey, Kimberly J.
    ANNALS OF SURGERY, 2012, 255 (01) : 140 - 146
12345